Brazil Clinical Chemistry Market Outlook to 2021 Now Available at iData Insights Brazil Clinical Chemistry Market Outlook to 2021 Summary GlobalDatas new report, "Brazil Clinical Chemistry Market Outlook to 2021", provides key market data on the Brazil Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis. Scope - Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Clinical Chemistry market. - Global corporate-level profiles of key companies operating within the Brazil Clinical Chemistry market. - Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize. Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landingpage.php?id=161222/brazil-clinical-chemistry-market-outlook-to-2021 To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landingpage.php?id=161222/brazil-clinical-chemistry-market-outlook-to-2021 Table of Contents 1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 3 1.2 List of Figures 3 2 Introduction 4 2.1 What Is This Report About? 4 1
2.2 Clinical Chemistry Market Segmentation 4 2.3 Definitions of Markets Covered in the Report 5 3 Clinical Chemistry Market, Brazil 8 3.1 Clinical Chemistry Market, Brazil, Revenue ($m), 2007-2014 8 3.2 Clinical Chemistry Market, Brazil, Revenue ($m), 2014-2021 10 3.2.1 Clinical Chemistry Analyzers Market, Brazil, Revenue ($m), by Segment, 2007-2014 12 3.2.2 Therapeutic Drug Monitoring Market, Brazil, Revenue ($m), by Segment, 2007-2014 14 3.2.3 Urine Analysis Market, Brazil, Revenue ($m), by Segment, 2007-2014 16 3.2.4 Clinical Chemistry Analyzers Market, Brazil, Revenue ($m), by Segment, 2014-2021 18 3.2.5 Therapeutic Drug Monitoring Market, Brazil, Revenue ($m), by Segment, 2014-2021 20 3.2.6 Urine Analysis Market, Brazil, Revenue ($m), by Segment, 2014-2021 22 3.3 Clinical Chemistry Market, Brazil, Distribution Share by Revenue ($m), 2013-2014 24 3.4 Clinical Chemistry Market, Brazil, Company Share by Revenue ($m), 2014 25 4 Overview of Key Companies in Brazil, Clinical Chemistry Market 27 4.1 Siemens Healthcare 27 4.1.1 Company Overview 27 4.2 F. Hoffmann-La Roche Ltd. 27 4.2.1 Company Overview 27 4.3 Danaher Corporation 27 4.3.1 Company Overview 27 4.4 Abbott Laboratories 28 4.4.1 Company Overview 28 4.5 Ortho-Clinical Diagnostics Inc. 28 4.5.1 Company Overview 28 4.6 ELITech Group 28 4.6.1 Company Overview 28 4.7 Mindray Medical International Limited 28 4.7.1 Company Overview 28
2
5 Clinical Chemistry Market Pipeline Products 30 6 Financial Deals Landscape 33 6.1 Partnerships 33 6.1.1 NoemaLife Enters into Distribution Agreement with Horiba Medical 33 7 Recent Developments 34 7.1 Strategy And Business Planning 34 7.1.1 Oct 22, 2014: ERBA Diagnostics Enters Brazilian Market; Offers In Vitro Diagnostics to Hospitals, Testing Labs and Physicians Clinics 34 8 Appendix 35 8.1 Research Methodology 36 8.1.1 Coverage 36 8.1.2 Secondary Research 36 8.1.3 Primary Research 36 8.1.4 Company Share Analysis 37 8.1.5 Distribution Share Analysis 37 8.2 GlobalData Consulting 37 8.3 Contact Us 37 8.4 Disclaimer 38 Read More http://www.idatainsights.com/reports-landing-page.php?id=161222/brazil-clinicalchemistry-market-outlook-to-2021 About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line. ContactUs: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com
3
About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects
4